Hrnciar J, Hrnciarová M, Lepej J, Okálová D, Kreze A, Chamulová M
Interná klinika A, nemocnice F. D. Roosevelta, Banská Bystrica.
Vnitr Lek. 1994 Sep;40(9):557-62.
The authors assessed in 20 subjects with mild or medium severe arterial hypertension basal and stimulated values of plasma renin activity (PRA) and aldosterone before onset of treatment and after 6-week therapy with enalapril (ENAP KRKA) or metoprolol (Vasocardin Slovakofarma). PRA and aldosterone secretion was stimulated by a vertical position and by administration of 40 mg furosemide by the i.v. This test proved suitable for assessment of secondary arterial hypertension in different forms of primary hyperaldosteronism and for expressing suspicion of renovascular hypertension and hypertension with affection of the renal arteries resp. Based on PRA levels, arterial hypertension can be divided into normorenin, high-renin and low-renin hypertension. This classification is, however, of no value for selection of treatment and the prognosis of hypertension. Each level of PRA can be associated with three different aldosterone levels. PRA and aldosterone did not correlate with urinary K, Na excretion nor with blood pressure. During treatment with ACE inhibitor PRA rose while basal as well as stimulated aldosterone levels declined. After administration of betablockers basal as well as stimulated PRA and aldosterone levels declined.
作者对20例轻度或中度重度动脉高血压患者进行了评估,测定了治疗开始前以及使用依那普利(ENAP KRKA)或美托洛尔(Vasocardin Slovakofarma)进行6周治疗后的血浆肾素活性(PRA)和醛固酮的基础值及刺激值。通过直立位和静脉注射40mg速尿来刺激PRA和醛固酮分泌。该试验被证明适用于评估不同形式原发性醛固酮增多症中的继发性动脉高血压,以及怀疑肾血管性高血压和累及肾动脉的高血压。根据PRA水平,动脉高血压可分为正常肾素型、高肾素型和低肾素型高血压。然而,这种分类对于治疗选择和高血压的预后没有价值。每个PRA水平都可能与三种不同的醛固酮水平相关。PRA和醛固酮与尿钾、钠排泄以及血压均无相关性。在使用ACE抑制剂治疗期间,PRA升高,而基础及刺激后的醛固酮水平下降。在给予β受体阻滞剂后,基础及刺激后的PRA和醛固酮水平均下降。